Novartis将2028年的年销售增长率预测提高到6%,这是由新推出的药物推动的。 Novartis raises annual sales growth forecast to 6% through 2028, driven by new drug launches.

诺华公司将其预测的年销售增长率提高到6%,到2028年为止,在强劲的市场表现和即将推出的药物推动下,销售增长率从5%上升至6%。 Novartis raised its sales growth forecast to 6% annually through 2028, up from 5%, driven by strong market performance and upcoming drug launches. 该公司预计2024-2029年增长率为5%,2027年业务收入比值为40。 The company expects a 5% growth rate for 2024-2029 and a 40%+ operating income margin by 2027. 诺华大学正侧重于创新药品,有超过15份即将提交的药物和30多个资产正在编审中,目的是增加其投资组合,维持2029年以后的增长。 Novartis is focusing on innovative medicines, with over 15 upcoming drug submissions and more than 30 assets in its pipeline, aiming to boost its portfolio and sustain growth beyond 2029.